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Abstract
Identification and characterization of protein-protein interactions between the host cell and parasites
both enhance our understanding of basic cell biology and provide insights into central processes of
parasite life cycles. Research on HIV-1 has broadened our knowledge of the various molecular events
involved. However, our understanding of how this virus interacts with the host cell at the level of
protein-protein interaction is still limited. Through these interactions the virus is able to recruit certain
cellular metabolic pathways for its replication. Here we summarize our current knowledge of
protein-protein interactions between HIV-1 and host cell factors during viral replication.
Review
Functional Genomics in HIV-1 Virus Replication:
Protein-Protein Interactions as a Basis for Recruiting
the Host Cell Machinery for Viral Propagation
ate protein-protein interactions between host cell and vi-
ral factors at any of these steps may lead to viral replica-
tion failure.
Early Events and Preintegration Complex (PIC)
Formation
The protein-protein interactions with the target cell start
with the HIV-1 envelope glycoproteins (gp120) binding to
the cell surface CD4 receptors and the chemokine core-
ceptors (reviewed in Doms and Trono, 2000), which leads
to the fusion of viral and cell membranes and to the virion
core entry into the cell cytoplasm. This is followed by the
disassembly of the HIV-1 virion core by a mechanism
whose exact molecular events are not yet fully under-
stood. This process has been suggested to involve inter-
actions between the viral capsid protein (CA) and host
cellular protein cyclophilin A (CyPA). The host CyPA that
is incorporated into the virion through interaction with the
viral CA protein is thought to promote the disassembly by
destabilizing the CA-CA interactions in the core (re-
viewed in Freed, 1998). The HIV-1 virion-associated mito-
gen-activated protein kinase (MAPK), another incorpo-
rated cellular protein, may contribute to the disassembly
through specific phosphorylation of its viral target pro-
teins (reviewed in Emerman, 1998). This generates the vi-
ral nucleoprotein complex, also called pre-integration
complex (PIC), an assembly of viral nucleic acids as well
as viral and cellular proteins in a high molecular weight
complex. Components of the PIC are the viral RNA
genome, the gag matrix antigen (gag MA), the gag p6
(p6), the nucleocapsid protein (NC), the viral protein R
(Vpr), the integrase (IN) and the reverse transcriptase (RT)
(reviewed in Stevenson, 1996). Cellular proteins have
also been detected in the PIC. They include the human
HMG I (Y) and the barrier to autointegration factors
(BAFs) (reviewed in Hindmarsh and Leis, 1999). In the
context of the pre-integration complex the viral genome
is reverse transcribed into double stranded DNA, import-
ed into the nucleus and integrated into the target
genome. The exact structure and composition of the PIC
is not fully understood, but it is most likely to be dynamic
with proteins entering or leaving the complex depending
on the need for their function and interactions with other
components of the complex. Physical interactions be-
tween the proteins and nucleic acids within the complex
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Introduction
Human immunodeficiency virus type 1 (HIV-1) is a com-
plex enveloped RNA lentivirus that causes AIDS (for de-
tails see Vogt, 1997). The HIV-1 virus encodes a few pro-
teins which are essential for the virus-specific replication
steps, and relies on the host cell for other functions nec-
essary for its propagation. The study of protein-protein
interactions between HIV-1 and the host cell provides an
important insight into the mediation of the links which al-
low the virus to harness cellular activities or alter cell reg-
ulatory mechanisms for its benefit.
The HIV-1 life cycle (Figure 1) consists of an early pre-
integration phase where viral attachment, cell entry, un-
coating, reverse transcription, nuclear import and inte-
gration of the proviral genome occur. The later
post-integration phase consists of viral gene expression,
virion assembly and maturation. HIV-1 recruits various
cellular metabolic pathways needed during its life cycle
and does this via protein-protein interactions. Inappropri-
are necessary to maintain a stable and proper conforma-
tion in the PIC, which is important for efficient function.
Any alteration in the precise arrangement of different
components of the complex is likely to have an effect on
reverse transcription as well as the later stages of the
virus replication.
Protein-Protein Interactions during Reverse
Transcription
Reverse transcription of the HIV-1 genome is a major
obligatory step, which has to be performed by the virus.
This is done by the viral reverse transcriptase enzyme, a
special type of DNA polymerase that can generate a dou-
ble-stranded proviral DNA from the viral RNA genome. A
great deal is known about the molecular and biochemical
basis of the HIV-1 reverse transcription process and the
reverse transcriptase enzyme itself (reviewed in Hottiger
and Hübscher, 1996). There are a number of events in-
volving protein-protein interactions between viral and
cellular factors which must occur before reverse tran-
scription can begin. These events lead to cell entry, un-
coating and to the establishment of a reverse transcrip-
tion initiation complex.
Specific protein-protein interactions with other viral
proteins in the preintegration complex are essential for
conformational stability and efficient viral DNA synthesis
by the RT enzyme. Direct physical protein-protein inter-
actions have been detected between the RT enzyme and
the two components of the PIC, the NC protein and the IN
enzyme (Lener et al., 1998; Wu et al., 1999), suggesting
that the influence of the two proteins on reverse tran-
scription may be through direct contacts with the RT in
the PIC (Lener et al., 1998; Wu et al., 1999). A number of
specific gag MA mutations have shown a reduction in re-
verse transcription efficiency, indicating possible roles for
gag MA-specific protein interactions in the maintenance
of PIC structure or stability (reviewed in Freed, 1998). A
number of studies have been published which have
shown that in quiescent cells HIV-1 reverse transcription
is initiated but fails to proceed to completion. Limited
pools of nucleotides in resting cells cannot fully explain
reverse transcription arrest and a possible involvement of
other cellular factors which might be missing has been
proposed (reviewed in Emerman, 2000). It is plausible
that these cellular proteins may associate with or are re-
cruited into the PIC through interactions with the reverse
transcriptase enzyme, other viral proteins or the viral nu-
cleic acids. Both the identities of such cellular proteins or
their roles during reverse transcription still have to be
clarified. One possibility is that some cellular proteins
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Fig. 1 A Schematic Overview of the HIV-1 Life Cycle.
All events indicated (attachment, cell entry, uncoating, reverse transcription, nuclear import, integration, transcription, nuclear export,
translation, virus assembly and budding) require some physical protein-protein interactions between viral and cellular proteins (for de-
tails see text).
might be required to join the complex to boost processiv-
ity of the RT enzyme. Cellular activation or transfection 
of resting T lymphocytes with the transcription factor,
nuclear factor of activated T cells (NFATc), can overcome
the block in reverse transcription. Thus, it has been sug-
gested that cellular activation or NFATc target gene acti-
vation makes the lymphocytes permissive for reverse
transcription (reviewed in Emerman, 2000).
Physical protein-protein interactions between cellular
proteins and HIV-1 proteins of the PIC have been demon-
strated for gag MA, NC, and RT (Hottiger et al., 1995;
Bukrinskaya et al., 1998; Liu et al., 1999). Numerous re-
ports have indicated that interactions with cell cytoskele-
ton proteins are essential in the HIV-1 life cycle, including
the early stages. Upon infection, the HIV-1 preintegration
complexes rapidly associate with the cytoskeletal com-
partment through specific protein-protein interactions
between the viral factors in the complex and actin micro-
filaments (Bukrinskaya et al., 1998). These interactions
are probably mediated through an interaction between
the phosphorylated form of gag MA and actin microfila-
ments (Bukrinskaya et al., 1998). In addition, HIV-1 RT
and HIV-1 NCp7, which also interact with actin microfila-
ments, may contribute to the reverse transcription com-
plex and cytoskeleton association. The cytoskeleton as-
sociation may promote both establishment of the reverse
transcription initiation complex and activation of reverse
transcription activity in the complex. The exact mecha-
nisms of reverse transcription activation by the cy-
toskeleton are not known, but some conformational
changes in the reverse transcription complex may be in-
duced upon interactions between actin and some pro-
teins in the viral nucleoprotein complex (Bukrinskaya et
al., 1998). Hottiger et al. (1995) have shown that HIV-1 RT
p66 can bind β actin, suggesting a mechanism of how cy-
toskeletal actin directly influences reverse transcription in
the viral complex. The host cytoskeleton provides a scaf-
fold along which the PICs can translocate into the nucle-
us or to other locations within the cell. This might be a
way in which the viral complex translocates to regions in
the cell where conditions are optimal for reverse tran-
scription in terms of availability of necessary cofactors.
Modulation of gag MA activity by phosphorylation has
been suggested. This enables the protein to play different
roles in the early and late stages of the HIV-1 life cycle.
Phosphorylation of gag MA may facilitate its release from
the phospholipid layer and enable the protein to associ-
ate with the virion core components or PIC (for reviews
see Stevenson, 1996; Freed, 1998). Additionally, the HIV-
1 RT ,Vpr, Vif, Rev and Nef have all been reported to be
modulated by phosphorylation. These events are likely
mediated through physical interactions between the viral
proteins and the appropriate cellular protein kinases. For
example, HIV-1 Nef protein associates with several pro-
tein kinases including p21-activated kinase 2 (PAK 2) (re-
viewed in Remkema and Saksela, 2000). A yeast two-hy-
brid screen for cellular proteins interacting with the HIV-1
RT enzyme identified the human NS1 binding protein
(Tasara, Hottiger and Hübscher, unpublished data), an
RNA binding protein involved in regulation of splicing.
Protein-protein interactions during HIV-1 genome re-
verse transcription can also be used to recruit cellular en-
zymatic functions for viral replication purposes. This
might be through selective incorporation into the virion
during budding or into the intracellular PIC after infection.
It has been shown that purified HIV-1 virions contain DNA
topoisomerase I activity which appears to be associated
with the virion core (Priel et al., 1990). DNA topoiso-
merase I could enhance the HIV-1 RT activity in vitro, but
the exact physiological mechanism of its action is not
known. This could include structural modifications in the
genomic RNA and newly synthesized DNA, leading to ef-
ficient viral genome reverse transcription by RT (Taka-
hashi et al., 1995).
The Vpr protein, another component of the PIC, has
been shown to play several roles in the HIV-1 life cycle. It
mediates nuclear transport of the PIC, G2 cell cycle ar-
rest and has some transcriptional transactivation activity.
Multiple protein-protein interactions between Vpr and
various cellular factors have been linked to its effects (re-
viewed in Emerman, 1996). In the context of the PIC its
nucleophilic properties are important for nuclear import
and it may also recruit DNA repair enzymatic activity into
the complex. Vpr directly interacts with the cellular DNA
repair protein, uracil DNA glycosylase (UNG) (reviewed in
Emerman, 1996). The Vpr-dependent incorporation of
UNG into the virion has been correlated with an influence
on the HIV-1 mutation rate in vivo (Mansky et al., 2000).
This suggests a possible mechanism by which the virus
limits the error rate during HIV-1 replication by employing
a cellular DNA repair enzyme. It might be one way for the
virus to keep the mutation rate within limits, just accept-
able for a beneficial genetic variation, and to avoid reach-
ing a lethal level. Vpr interaction with the cellular Lys-
tRNA synthetase has been shown in the yeast two-hybrid
system and also in vitro. The physiological significance of
this interaction has not been confirmed, but it has been
suggested that it might have an influence on the initiation
of reverse transcription (Stark and Hay, 1998).
Protein-Protein Interactions during PIC Nuclear
Import
The HIV-1 PIC has the ability to enter the nucleus in non-
dividing cells due to its nucleophilic properties conferred
by the viral proteins in the complex. The HIV-1 gag MA, IN
and Vpr are the karyophilic determinants in the PIC acting
in complementarity (reviewed in Stevenson, 1996). Pro-
tein-protein interactions between these viral components
in the context of the PIC and the cellular nuclear import
proteins mediate nuclear import. gag MA and IN both
carry SV40-like nuclear localization signals (NLS) and use
the importin α/importin β system for nuclear import (Gal-
lay et al., 1996, 1997). The basic type NLS of gag MA and
IN mediate direct interactions with the importin α subunit
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in the importinα/β heterodimer of the cytosolic nuclear
transport receptor. This complex docks the PIC at the nu-
clear pore complex (NPC) through the interaction of im-
portin β with nucleophorins. Physical protein-protein in-
teractions between karyopherin/importin α (Rch 1) and
gag MA and IN in the context of the HIV-1 PIC have been
shown (Gallay et al., 1996, 1997).
The Vpr function in HIV-1 PIC nuclear import is com-
plementary but mechanistically distinct from that of gag
MA and IN. Since it lacks a classical NLS, a number of
mechanisms for Vpr’s role in PIC nuclear import have
been suggested from different groups (Jenkins et al.,
1998; Vodicka et al., 1998). In one model, Vpr functional-
ly replaces the karyopherin β subunit of the cellular nu-
clear import machinery (Vodicka et al., 1998). Consistent
with this theory, direct physical interactions between Vpr
and both karyopherin α and nucleophorins have been
shown (Vodicka et al., 1998). Alternative pathways of Vpr-
dependent PIC nuclear import propose that it is mediat-
ed through direct interactions between regions in the car-
boxy- and amino-termini of Vpr and the NPC proteins
(Jenkins et al., 1998). Thus, various strategies are em-
ployed for the HIV-1 PIC entry into the nucleus as a result
of concerted protein-protein interactions between the
nuclear import proteins and the virally encoded
karyophillic proteins. These viral mechanisms increase
the probability of nuclear entry by the PIC for successful
viral replication.
Protein-Protein Interactions and Proviral
Genome Integration
Once imported into the nucleus the proviral genome has
to be integrated into suitable areas of the target genome
where it is accessible for viral gene expression by the cel-
lular transcription machinery. Integration is performed by
the virally encoded IN enzyme and requires recognition
and processing of short DNA sequences at the ends of
long terminal repeats (LTR) (reviewed in Hindmarsh and
Leis, 1999). The virus also employs protein-protein inter-
actions with host factors that can target the PIC complex
to appropriate sites for integration. HIV-1 IN enzyme has
been shown to directly interact with host protein Ini1 (in-
tegrase interactor 1 protein), also known as hSNF5, and
this interaction stimulates the integration activity in vitro
(Kalpana et al., 1994). Ini1/hSNF5 is a human homolog of
yeast transcription factor SNF5. It is a component of the
human chromatin remodeling SWI/SNF complex. It
seems that through protein-protein interaction the HIV-1
PIC is tethered to a chromatin remodeling complex. This
might be one way to ensure the PIC access to target DNA
located in transcriptionally active regions or associated
open chromatin regions. Such a strategy localizes the in-
tegrated viral genome in areas where there are higher
chances of success in terms of subsequent viral gene
expression. Other host cell proteins also influence HIV-1
integrase function. The human high mobility group (HMG)
proteins are required for PIC integration activity in vitro
and can enhance the integration efficiency by purified
HIV-1 integrase protein. Another host protein, barrier-to-
autointegration protein (BAF) may be used by the virus
PIC to prevent the self-destructive process of autointe-
gration prior to integration into target DNA (reviewed in
Hindmarsh and Leis, 1999).
Protein-Protein Interactions and HIV-1 Gene
Expression
Integration places the HIV-1 proviral genome under tran-
scriptional regulation by the host cell transcriptional ma-
chinery (Nabel, 1993). In addition, the virus has evolved
its own form of transcription regulation mechanism by
encoding its own transactivating factor, Tat, a potent ac-
tivator of the HIV-1 LTR promoter (reviewed in Karn,
1999). Protein-protein interactions between Tat and its
cellular cofactors may be direct or dependent on the TAR
(Tat activating region) RNA element bridging. The recruit-
ment of Tat to the HIV-1 LTR through TAR binding also re-
cruits Tat-associated cellular proteins such as Cdk9 ki-
nase. Tat associates with the cyclinT-Cdk9 complex of
the positive transcription elongation factor (P-TEFb)
complex through interactions involving the loop and
bulge regions of the TAR element. The Tat-associated
CdK9 kinase then hyperphosphorylates the RNA poly-
merase II carboxy-terminal domain (CTD), converting the
initiated holoenzyme complex from a non-processive into
a processive form. Rodent cyclin T1 or human cyclin T1
mutants which abolish the Tat-cyclin T1 interactions all re-
sult in loss of Tat transactivation activity on the HIV-1 pro-
motor. Physical and functional interactions between Tat
and the transcriptional coactivator p300 or its related cel-
lular transcription coactivator, CREB binding protein
(CBP), have been shown (Hottiger and Nabel, 1998). The
virus seems to use this interaction to recruit histone
acetyltransferase (HAT) activity to the integrated HIV-1
promotor to relieve chromatin structure-induced block-
age on HIV-1 LTR transcription (Hottiger and Nabel,
1998). p300/CBP can also directly acetylate the Tat pro-
tein and this modification might be important for tran-
scription activation of the HIV-1 promotor by Tat (Ott et
al., 1999). Direct protein-protein interactions between Tat
and transcription factor SP1, general transcription factor
TFIID, and TIP 30 (30 kDa Tat interacting protein) have
also been found. The role of these interactions in HIV-1
transactivation has not been defined (reviewed in Karn,
1999).
Protein-Protein Interactions and mRNA Nuclear
Export
The viral mRNA is processed by the cellular splicing ma-
chinery before nuclear export to the ribosomes for trans-
lation. However, for the expression of its late gene prod-
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ucts and for genomic RNA, unprocessed RNA transcripts
with functional introns have to be exported into the cyto-
plasm as well. Meanwhile, the cellular machinery would
retain all unspliced transcripts until they are processed 
or degraded, the HIV-1 has overcome this by encoding
the sequence-specific nuclear export factor Rev protein
which can shuttle between the nucleus and cytoplasm
(reviewed in Cullen, 1998; Emerman, 1998). Rev protein-
protein interactions coopt the cellular nuclear export
machinery for the virus’ benefit. It enters the nucleus
through physical interactions with importin β via its amino
terminal arginine-rich stretch, serving as both an NLS and
an ARM (arginine-rich RNA binding motif). The nucle-
ophorin-importin β interaction causes the Rev-importin β
complex to dock at the nuclear pore, followed by nuclear
translocation and Rev release through a process involv-
ing importin β-Ran GTP interaction. Rev molecules bind
to the Rev response element (RRE), an RNA stem-loop
structure in viral mRNA. The resulting ribonucleoprotein
complex interacts with Ran GTP bound nuclear export
protein exportin 1 (Crm 1) through the carboxy-terminally
located Rev nuclear export signal (NES). Exportin 1 in
turn directly interacts with the nucleophorins, leading to
export of the Rev bound viral mRNAs into the cytoplasm.
Its not clear how HIV-1 mRNAs are released once in the
cytoplasm, but most likely the virus takes advantage of
other protein-protein interactions probably between Rev
and the nuclear import proteins.
Protein-Protein Interactions in Viral Assembly
and Budding
During assembly, Gag polyproteins (Pr55gag and Pr160gag)
have to be transported to the sites of viral budding at the
cell membrane. The key for membrane targeting the Gag
polyproteins is the N-terminal myristoylation signal. This
cotranslational modification of viral Gag polyproteins is
mediated through interactions between viral proteins and
the appropriate cellular enzymes. The nature of host fac-
tors that may be involved in assembly and budding is not
yet clear. In a recent study Parker and Hunter (2000) de-
scribed an insect cell line specifically defective in trans-
port and assembly of retroviral particles, which may be
due to the lack of certain host factors in the particular in-
sect cell line used in their work. Interactions of Gag pre-
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Table 1 Protein-Protein Interactions between HIV-1 and Cellular Factors and Their Pos-
sible Functional Significance in the Viral Life Cyclea.
Event HIV-1 Virus Cellular partners Functional significance
protein
Early Envelope (gp120) CD4 Cell entry
Chemokine coreceptors
CA Cyclophilin A (CypA) Disassembly
Pre- gag MA Importin α PIC nuclear import
integration Actin PIC and cytoskeleton
interations
RT Actin PIC and cytoskeleton
interactions
IN Importin α PIC nuclear import
Integrase interactor 1 PIC recruitment to target
(Ini 1) genome and integration
promotion
Vpr Importin α PIC nuclear import
Importin β
Nucleophorins
Uracil DNA Increases the fidelity of
glycosylase (UNG) HIV-1 replication
Post- Tat Cyclin T1 PTEFb complex
integration recruitment to TAR
p300/CBP HAT recruitment to the
integrated HIV-1 LTR.
Modulation of HIV-1 Tat
activity by acetylation
Rev Improtin β Rev nuclear import
Exportin 1/Crm 1 Nuclear export of viral
mRNAs
Gag Precursors Cytoskeleton and cell Intracellular transport,
(Pr55gag, Pr160gag) membrane viral assembly and
budding
aFor details and abbreviations see text.
cursors with the cytoskeleton play an important role in
their intracellular transport to the viral assembly sites at
the cell membrane. Protein-protein interactions between
the Gag precursor proteins themselves and also with oth-
er viral proteins are important for both assembly and in-
corporation of other viral proteins into the viral particles
(reviewed in Freed, 1998). Genomic RNA packaging re-
quires Gag NC domain interaction with the viral RNA
packaging sequence (psi). The human Staufen protein
(hStau), a double-stranded RNA binding protein which
also binds HIV-1 genomic RNA, has been suggested to
promote viral genomic RNA selection and packaging into
assembling virions (Mouland et al., 2000).
Conclusions
While our knowledge of the various viral proteins at the
molecular level has been greatly enhanced over the last
ten years, details of protein-protein interactions between
the individual viral and the cellular factors still remain a
challenge to be solved in more detail. The post genomic
era will bring more applications of functional genomics
and proteomics methods for protein-protein interaction
studies and will shed more light on how this very impor-
tant pathogen is able to exploit cellular functions and the
same time evade defense mechanisms. The elucidation
of protein interactions between HIV-1 and the host cell
machinery will improve our understanding of both host
cell biology and viral replication and might reveal novel
therapeutic targets for this devastating pathogen.
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